- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-381
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.8¢ |
Change
-0.003(0.26%) |
Mkt cap ! $1.081B |
Open | High | Low | Value | Volume |
95.0¢ | 95.8¢ | 93.5¢ | $747.0K | 789.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 63514 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 64557 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 57490 | 0.945 |
17 | 109942 | 0.940 |
16 | 172765 | 0.935 |
21 | 226405 | 0.930 |
12 | 83380 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 55937 | 18 |
0.955 | 54509 | 11 |
0.960 | 54024 | 11 |
0.965 | 70796 | 6 |
0.970 | 50119 | 5 |
Last trade - 11.51am 28/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
Previous Video
Next Video
SPONSORED BY The Market Online